… treated patients who were also transitioned to alendronate – WALTHAM, Mass., Feb. 01, 2017 (GLOBE NEWSWIRE) — Radius Health, Inc. (Nasdaq: RDUS ), a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in …